Hecla Mining heads into its May 5 earnings call with the stock down nearly 8% on the week — but with short sellers quietly trimming and the Street just turning more constructive.
The most notable development is the freshest analyst action. Canaccord Genuity upgraded HL to Buy from Hold on April 29, setting a $24 target — a 37% premium to Wednesday's close of $17.47. That is the first rating upgrade from the analyst panel in several months and lands less than a week before Q1 results. The broader panel is split, with three Buys against five Hold-equivalent ratings. Targets from earlier this year cluster between $24 and $36.50, though the HC Wainwright $36.50 target warrants a note of caution given the current price — the spread is wide enough to raise a data-freshness question, even though it was reported in January 2026. The EV/EBITDA multiple has contracted about 1.5 turns over the past month, now running near 10.9x, and the PE has declined by roughly 4.5 points over the same stretch. On factor scores, the EPS surprise rank is solid at the 71st percentile, and the 90-day EPS momentum sits at 61 — but the 30-day read has weakened to just 13, suggesting near-term estimate revisions have turned more cautious ahead of the print.
Short interest tells a more relaxed story than the price action implies. Shorts have pulled back about 3.3% over the week to roughly 4.8% of the free float — after peaking above 5% in mid-April. The retreat has been orderly, coming largely in the April 22–24 window when shares were already under pressure. Borrowing costs remain undemanding at around 0.43% APR and have been rangebound for six weeks. Availability in the lending pool is ample — the borrow market shows no signs of tightening. That combination points to positioning that is cautious but far from crowded on the short side.
Options tell a somewhat different story. The put/call ratio has climbed to 0.53 — its highest reading of the past year and running roughly 1.6 standard deviations above the 20-day mean of 0.49. The shift is gradual but consistent: the PCR was tracking in the 0.46–0.49 range through most of April before stepping up over the final days of the month, coinciding with the broader sector pullback. Silver peers have had a rough week: CDE dropped over 10%, while PAAS and AG both fell around 9%. HL at -7.9% actually held up marginally better than some close comps, but the direction of travel is uniform across the group.
On the institutional side, the register is anchored by large passive holders — BlackRock (13%) and Vanguard (9.8%) together hold nearly a quarter of shares. More active flows are smaller: Goldman Sachs and Northern Trust both added modestly in Q1. Arrowstreet stood out with a larger build of roughly 5.9 million shares as of December 2025, though that filing is now several months old. Insider activity from early March was largely award-related, with the CFO and COO each selling small tranches into unvested stock compensation — routine in character and at prices near $24.63, well above the current level.
The Q1 earnings print on May 5 is the immediate focal point. The most recent earnings history shows HL moved +7.3% the day after its February 2026 release. The bull thesis rests on elevated silver and gold prices, 27% year-on-year silver sales growth, and the potential for free cash flow to support balance sheet flexibility. Bears point to the planned hoist downtime flagged for Q3, a debt load that has moved significantly, and guidance that sat slightly below consensus expectations at the last update. With options pricing in more downside hedging than usual, and the stock near a multi-month low, the focus is squarely on whether Q1 production and revenue numbers validate the silver price tailwind.
See the live data behind this article on ORTEX.
Open HL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
